CIK: 0001388551
Total reported value
$4.0M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RZLT | Rezolute INC | Stock-Other | 81.70% | — | +23.87% | |
| 2 | GLD | Spdr Gold Shares | ETF-Commodities | 11.33% | +17.00% | +47.13% | |
| 3 | BRK-B | Berkshire Hathaway Inc-cl B | Stock-Other | 1.43% | +0.32% | +3.01% | |
| 4 | BRD1EUR | Mind Medicine Mindmed INC | Stock-Other | 1.39% | -4.91% | EXIT | |
| 5 | ELVN | Enliven Therapeutics INC | Stock-Other | 1.17% | — | — | |
| 6 | CMPX | Compass Therapeutics INC | Stock-Other | 0.82% | -3.70% | EXIT | |
| 7 | BCAX | Bicara Therapeutics INC | Stock-Other | 0.76% | — | — | |
| 8 | KYTX | Kyverna Therapeutics INC | Stock-Other | 0.60% | -0.09% | — | |
| 9 | LXEO | Lexeo Therapeutics INC | Stock-Other | 0.50% | -1.25% | — | |
| 10 | IKT | Inhibikase Therapeutics INC | Stock-Other | 0.12% | -0.17% | — | |
| 11 | SABS | Sab Biotherapeutics INC | Stock-Other | 0.10% | -0.92% | EXIT | |
| 12 | CNTX | Context Therapeutics INC | Stock-Other | 0.08% | -0.63% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RZLT | Rezolute INC | +6.4% | +23.87% | Add |
| 2 | GLD | Spdr Gold Shares | +4% | +47.13% | Add |
| 3 | CNTX | Context Therapeutics INC | -0.1% | — | Unchanged |
| 4 | KYTX | Kyverna Therapeutics INC | -0.3% | — | Unchanged |
| 5 | IKT | Inhibikase Therapeutics INC | -0.6% | — | Unchanged |
| 6 | LXEO | Lexeo Therapeutics INC | -0.7% | — | Trim |
| 7 | CMPX | Compass Therapeutics INC | -0.8% | +23.09% | Add |
| 8 | BCAX | Bicara Therapeutics INC | -2.1% | — | Unchanged |
| 9 | BRD1EUR | Mind Medicine Mindmed INC | -2.5% | -20.73% | Trim |
| 10 | BRK-B | Berkshire Hathaway Inc-cl B | -3.5% | +3.01% | Add |
| 11 | ELVN | Enliven Therapeutics INC | — | NEW | New buy |
| 12 | CRDF | Cardiff Oncology INC | — | EXIT | Sold out |
| 13 | SABS | Sab Biotherapeutics INC | — | NEW | New buy |
| 14 | TORCEUR | Adicet Bio INC | — | EXIT | Sold out |